Genetic and genomic lab testing creates 116,000 U.S. jobs

Friday, January 20, 2012 03:46 PM

Driven by rapid innovation made possible in large part by the mapping of the human genome, genetic and genomic clinical laboratory testing generates 116,000 U.S. jobs and contributes $16.5 billion annually to the U.S. economy, according to a new report by the Battelle Memorial Institute.  Because this industry sector is still in the early stages of development, according to the report, much future growth is expected to occur.

The report said the industry sector's ability to innovate and produce cutting-edge genetic testing services and products supports about 44,000 direct jobs and generates about another 73,000 jobs in key supplier industries, such as real estate, food services and wholesale trade businesses, as well as a result of consumer spending by laboratory employees.  Together, the genetic and genomic laboratory testing sector-related workforce received nearly $6 billion in wages and benefits in 2009.  It also generated $657 million in estimated state and local tax revenue and nearly $1.2 billion in federal taxes in 2009. 

"The fact that genetic and genomic testing has created 116,000 jobs and $6 billion in personal income for U.S. workers in the middle of one of the country's worst recessions should be noted by U.S. policy leaders," said Alan Mertz, president of the American Clinical Laboratory Association (ACLA).

Battelle said that comparatively high levels of wages and salaries are provided within the industry, along with sound benefits packages.  It found that the annual average personal income of a worker in this sector was about $57,000 in 2009—a significant wage premium as compared to roughly $45,000 in the overall U.S. economy.

The report was sponsored by ACLA and its educational arm, Results for Life.

Share:          
CLINICAL TRIAL RESOURCES

Search:

NEWS ONLINE ARCHIVE

Browse by:

CWWeekly

December 17

Medici Global says its Alzheimer's Facebook page demonstrates the need for more early detection trials

Analysts: Expect more equity purchases of CROs in 2013

Already a subscriber?
Log in to your digital subscription.

Subscribe to CWWeekly.

The CenterWatch Monthly

January 2013

Parexel celebrates 30 years of change, growth
CRO's founder and chairman reflects on challenges of the past, present and future

Strategies for increasing patient diversity in trials
Sponsors look to improve racial, ethnic recruitment without going overseas

Already a subscriber?
Log in to your digital subscription.

Purchase the January issue.

Subscribe to The CenterWatch Monthly.

December 2012

Publicity, regulation tightening reins on use of KOLs
Debate rages over need to revamp how sponsors use, pay medical experts

Time may be right to makeover the investigator brochure
Size, complexity prevent critical document from being thoroughly read

Already a subscriber?
Log in to your digital subscription.

Purchase the December issue.

Subscribe to The CenterWatch Monthly.

JobWatch centerwatch.com/jobwatch

Featured Jobs